QT
SUPN icon

Quantamental Technologies’s Supernus Pharmaceuticals SUPN Stock Holding History

Quantamental Technologies’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,958
Closed -$239K – 560
2023
Q2 		$239K Buy
+7,958
New +$278K 0.1% 346
2019
Q4 		– Sell
-9,469
Closed -$260K – 1233
2019
Q3 		$260K Buy
+9,469
New +$281K 0.08% 401
2019
Q2 		– Sell
-6,460
Closed -$226K – 1784
2019
Q1 		$226K Buy
6,460
+5,833
+930% +$217K 0.1% 329
2018
Q4 		$21K Buy
+627
New +$27K 0.01% 1012

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantamental Technologies's SUPN Position: Q3 2023 in Review

Quantamental Technologies sold out of Supernus Pharmaceuticals (SUPN) in Q3 2023, closing a stake of 7,958 shares — an estimated $239K sold.

Quantamental Technologies first reported a position in SUPN in Q4 2018 and held it in 4 quarters. The position peaked at $260K in Q3 2019. 238 funds tracked by Wall St. Rank hold SUPN as of Q3 2023.

  • Quantamental Technologies reported no remaining Supernus Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 7,958 Supernus Pharmaceuticals shares in Q3 2023, an estimated $239K.
  • Quantamental Technologies first reported a position in Supernus Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Supernus Pharmaceuticals position peaked at $260K in Q3 2019.
  • 238 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.